Theriva Biologics, Inc. (TOVX)

0.2431 +0.01 (+3.40%) USD  |  NYAM  |  Aug 25, 15:45
More

Theriva Biologics EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Fiscal Year Chart
Start Trial

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 12, 2026 --
May 06, 2026 --
March 13, 2026 --
August 12, 2025 --
Date Value
May 15, 2025 --
May 09, 2025 --
November 15, 2023 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Nkarta, Inc. Upgrade
Unicycive Therapeutics, Inc. Upgrade
OnKure Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade